L & S Advisors Inc Arvinas, Inc. Transaction History

L & S Advisors Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$36.38 - $52.31 $2.92 Million - $4.2 Million	80,202 New	80,202 $3.31 Million
Q1 2021 May 10, 2021	SELL	$58.19 - $91.37 $174,570 - $274,110	-3,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$20.19 - $84.93 $60,570 - $254,790	3,000 New	3,000 $255,000

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on L & S Advisors Inc with notifications on news.